The influence of phase behavior on the morphology of protein α-chymotrypsin prepared via a supercritical anti-solvent process

被引:17
作者
Chang, Shan-Chun [1 ]
Lee, Ming-Jer [1 ]
Lin, Ho-Mu [1 ]
机构
[1] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Sect 4, Taipei 10607, Taiwan
关键词
supercritical anti-solvent process; alpha-chymotrypsin; micronization; phase behavior;
D O I
10.1016/j.supflu.2007.11.001
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Ultra-fine particles of alpha-chymotrypsin were produced with a supercritical anti-solvent (SAS) technique by using dimethyl sulfoxide (DMSO) as a solvent and carbon dioxide as an anti-solvent. According to the vapor-liquid equilibrium (VLE) phase diagram of DMSO +carbon dioxide, the precipitation experiments have been conducted in different phase regions, including supercritical, superheated vapor, and vapor-liquid phase coexistence zones. It was found that the phase behavior of the mixtures during precipitation governed the product's morphology. Uniform networked nano-particles were obtained as the precipitation was implemented in the supercritical region. The uniformity of the resulting products became worse when the particles were precipitated around the critical region. Irregular micro-scale aggregated particles were formed in the superheated region, while both dense cake and spherical clusters were produced in the vapor-liquid coexistence region. A continuous stirred tank reactor (CSTR) model was applied to calculate the dynamic composition variations of mixtures in precipitator during the particle formation process. The crystalline and thermal property of the original and the SAS processed samples were analyzed by a wide-angle X-ray scattering (WAXS), a differential scanning calorimeter (DSC) and a thermogravimetric analyzer (TGA), respectively. No significant changes were found after SAS treatment. Besides, the biological activity of the SAS processed (x-chymotrypsin was retained in a range of 30-75% of the original protein. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 24 条
[1]   PULMONARY DELIVERY OF PEPTIDE DRUGS - EFFECT OF PARTICLE-SIZE ON BIOAVAILABILITY OF LEUPROLIDE ACETATE IN HEALTHY MALE-VOLUNTEERS [J].
ADJEI, A ;
GARREN, J .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :565-569
[2]   Phase equilibria of dimethyl sulfoxide (DMSO) plus carbon dioxide, and DMSO plus carbon dioxide plus water mixtures [J].
Andreatta, A. E. ;
Florusse, L. J. ;
Bottini, S. B. ;
Peters, C. J. .
JOURNAL OF SUPERCRITICAL FLUIDS, 2007, 42 (01) :60-68
[3]   Nanoparticles formation for metallocene catalyzed cyclic olefin copolymer via a continuous supercritical anti-solvent process [J].
Chang, Shan-Chun ;
Lee, Ming-Jer ;
Lin, Ho-Mu .
JOURNAL OF SUPERCRITICAL FLUIDS, 2007, 40 (03) :420-432
[4]   Opening new operating windows for polymer and protein micronisation using the PCA process [J].
de Diego, YP ;
Pellikaan, HC ;
Wubbolts, FE ;
Borchard, G ;
Witkamp, GJ ;
Jansens, PJ .
JOURNAL OF SUPERCRITICAL FLUIDS, 2006, 36 (03) :216-224
[5]   APPLICATION OF SUPERCRITICAL FLUIDS FOR THE PRODUCTION OF SUSTAINED DELIVERY DEVICES [J].
DEBENEDETTI, PG ;
TOM, JW ;
YEO, SD ;
LIM, GB .
JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) :27-44
[6]  
GALLAGHER PM, 1989, ACS SYM SER, V406, P334
[7]  
Gupta R. B., 2002, US patent, Patent No. 20020000681
[8]   Stabilization of proteins in dry powder formulations using supercritical fluid technology [J].
Jovanovic, N ;
Bouchard, A ;
Hofland, GW ;
Witkamp, GJ ;
Crommelin, DJA ;
Jiskoot, W .
PHARMACEUTICAL RESEARCH, 2004, 21 (11) :1955-1969
[9]   Particle design using supercritical fluids: Literature and patent survey [J].
Jung, J ;
Perrut, M .
JOURNAL OF SUPERCRITICAL FLUIDS, 2001, 20 (03) :179-219
[10]   STABILITY OF PROTEIN PHARMACEUTICALS [J].
MANNING, MC ;
PATEL, K ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1989, 6 (11) :903-918